Bristol Myers Squibb CEO on $15B deal with China’s Hengrui Pharma

ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email

Bristol Myers Squibb CEO Chris Boerner sits down with CNBC’s Angelica Peebles at the American Society of Clinical Oncology’s annual meeting to discuss the company’s latest cancer drug data, its $15 billion deal with China’s Hengrui, and more.

04:14

Mon, Jun 1 202611:34 AM EDT